CVS Health Corporation $CVS Shares Acquired by Cantor Fitzgerald Investment Advisors L.P.

Key Points

• Cantor Fitzgerald Investment Advisors L.P. increased its stake in CVS Health Corporation by 1.6%, holding 409,735 shares valued at approximately $28.26 million.
• CVS Health recently upgraded by multiple analysts, with UBS raising its price target from $67.00 to $79.00 and a consensus target price now at $78.25.
• The company declared a quarterly dividend of $0.665 per share, representing an annualized dividend yield of 3.5%, to be paid on November 3rd.

Cantor Fitzgerald Investment Advisors L.P. boosted its stake in CVS Health Corporation (NYSE:CVS - Free Report) by 1.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 409,735 shares of the pharmacy operator's stock after buying an additional 6,615 shares during the period. CVS Health accounts for approximately 2.0% of Cantor Fitzgerald Investment Advisors L.P.'s investment portfolio, making the stock its 8th largest holding. Cantor Fitzgerald Investment Advisors L.P.'s holdings in CVS Health were worth $28,264,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Vanguard Group Inc. increased its stake in shares of CVS Health by 0.8% in the first quarter. Vanguard Group Inc. now owns 118,335,394 shares of the pharmacy operator's stock valued at $8,017,223,000 after purchasing an additional 969,027 shares during the period. Dodge & Cox increased its position in CVS Health by 4.8% in the 1st quarter. Dodge & Cox now owns 73,459,122 shares of the pharmacy operator's stock valued at $4,976,856,000 after acquiring an additional 3,353,223 shares during the period. Invesco Ltd. raised its stake in CVS Health by 13.2% during the 1st quarter. Invesco Ltd. now owns 20,413,853 shares of the pharmacy operator's stock valued at $1,383,039,000 after acquiring an additional 2,375,764 shares in the last quarter. Price T Rowe Associates Inc. MD grew its stake in shares of CVS Health by 14.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 15,309,289 shares of the pharmacy operator's stock worth $1,037,205,000 after purchasing an additional 1,942,886 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of CVS Health by 5.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 13,647,873 shares of the pharmacy operator's stock valued at $924,643,000 after purchasing an additional 728,924 shares during the period. Institutional investors own 80.66% of the company's stock.

Insider Transactions at CVS Health

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the business's stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the sale, the director directly owned 22,156 shares of the company's stock, valued at $1,573,519.12. The trade was a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.22% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of recent analyst reports. UBS Group upgraded shares of CVS Health from a "neutral" rating to a "buy" rating and increased their target price for the company from $67.00 to $79.00 in a research report on Monday, August 18th. Morgan Stanley upped their price target on shares of CVS Health from $80.00 to $82.00 and gave the stock an "overweight" rating in a research note on Friday, August 1st. Sanford C. Bernstein raised their price objective on shares of CVS Health from $72.00 to $77.00 and gave the company a "market perform" rating in a research note on Friday, September 5th. Cowen restated a "buy" rating on shares of CVS Health in a research report on Monday, August 4th. Finally, Jefferies Financial Group lifted their price target on CVS Health from $74.00 to $80.00 and gave the company a "buy" rating in a research report on Monday, June 30th. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $78.25.

CVS Health Trading Up 1.9%

CVS Health stock opened at $76.84 on Thursday. The firm has a market capitalization of $97.46 billion, a price-to-earnings ratio of 21.46, a P/E/G ratio of 0.83 and a beta of 0.60. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $77.54. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80. The company has a 50 day moving average price of $70.00 and a 200 day moving average price of $67.19.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.35. The firm had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The business's revenue for the quarter was up 8.4% on a year-over-year basis. During the same period in the prior year, the business earned $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Research analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be paid a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.5%. CVS Health's dividend payout ratio (DPR) is 74.30%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.